Advertisement
Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc. (TERN) Stock Overview

Explore Terns Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

TERN●NASDAQ
HealthcareBiotechnology
$52.95
$0.02(0.03%)
U.S. Market opens in 16h 8m
Advertisement

Terns Pharmaceuticals, Inc. (TERN)

Meyka AI Score

Z

Key Financials

Market Cap4.8B
P/E Ratio-51.28
EPS (TTM)$-1.03
ROE-0.20%
Fundamental Analysis

AI Price Forecasts

1 Month$43.87
3 Months$56.71
1 Year Target$25.83

TERN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Terns Pharmaceuticals, Inc. (TERN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 75.63, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $25.83.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -51.28 and a market capitalization of 4.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
24.50%
6-Month Change
95.17%
Year-to-Date (YTD) Change
31.06%
1-Year Change
1408.55%
3-Year Change
334.02%
5-Year Change
230.52%
All-Time (Max) Change
187.93%

Contact Information

https://www.ternspharma.com
650 525 5535
1065 East Hillsdale Boulevard, Foster City, CA, 94404

Company Facts

590 Employees
IPO DateFeb 5, 2021
CountryUS

Frequently Asked Questions